AstraZeneca

Open: 63.92 Close: 63.83 Change: -0.09

Our AI found unexpected things about AstraZeneca.

How much time have you spent trying to decide whether investing in AstraZeneca? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, vaccine, …

Concept Map

Semantic Network

Stock Summary

AstraZeneca PLC focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa,.

Today's Summary

London-listed shares of Astra Zeneca were down 3.7% at 1219 GMT, while the broader STOXX Health Care index was off 1%. Astrazenecas is carrying a Zacks Rank of #3 (Hold #3)

Today's News

AstraZeneca, daiichi sankyos enhertu gets approval in eu for lung cancer treatment - marketwatch.com. Astra.Zeneca said that its drug Enhertu, which it developed in partnership with Daiichi Sankyo, has been approved. AstraZeneca shares fall as lung cancer drug trial data abstract disappoints. London-listed shares of Astra Zeneca were down 3.7% at 1219 GMT, while the broader STOXX Health Care index was off 1%. Astrazeneca plc (azn) stock price, news, quote & history - yahoo finance.com. AstraZeneca PLC (AZN) Stock Price, News, Quote & History - Yahoo Finance Home Mail News and Sports Entertainment. AstraZeneca PLC (AZN) , DSKYF , DSNKY , SA News Editor Dulan Lokuwithana. Shares of Astra Zeneca and its partner Daiichi Sankyo fell Wednesday as Wall Street reacted to late-stage data for the companies antibody drug conjugate datopotamab deruxtecan. Astrazeneca awards funding to eight innovative research projects - european pharmaceutical manufacturer. Astrazenecas is carrying a Zacks Rank of #3 (Hold #3) With respect to respect to the status of AstraZeneca. Shares of Anglo-Swedish pharma heavyweight Astrazeneca outperformed the index, closing up 2.7%. Johnson & Johnson upgraded their full year sales view, Hewson said. ascentage and astrazeneca to conduct cll/sll therapy trial. Astrazeneca Foundation Awards 12 Nonprofit Organizations More Than $2M to Advance Health Equity. First data from four pivotal Phase III trials at ESMO. AstraZeneca, Daiichi Tout Phase III Breast Cancer Data in Challenge to Gilead. AstraZenecas COVID-19 vaccine is being tested to prevent infection of SARS-CoV-2, which causes COVID. Vaxzevria, when given as a third dose booster, increased the immune response. AstraZeneca reported third-quarter 2021 COVID-19 vaccine sales of $1.05 billion. Vaccine is not authorized for use in the U.S. AstraZeneca announced Vaxzevria had been granted special approval for emergency use in Japan for active immunization of individuals aged 18 years and older to prevent COVID-19 caused by SARS-CoV-2. Thrombosis Canada says AstraZeneca vaccine not at increased risk of developing blood clots compared to the general population. European Medicines Agency: benefits still outweigh the risks. AstraZenecas COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) in Australia. The WHO listed two versions of the Astra Zeneca/Oxford COVI-19 vaccines for emergency use. COVID-19 Vaccine AstraZeneca has been granted emergency use authorization in India and Argentina, the Dominican Republic, El Salvador, Mexico, and Morocco for adults active immunization. Human trials of a coronavirus vaccine combining the Sputnik V Vaccine with the Astra.

Stock Profile

"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom."

Keywords

This document will help you to evaluate AstraZeneca without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, vaccine, COVID19, trial, Astra, Astrazeneca, say, and the most common words in the summary are: astrazeneca, vaccine, cancer, covid19, news, press, release, . One of the sentences in the summary was: London-listed shares of Astra Zeneca were down 3.7% at 1219 GMT, while the broader STOXX Health Care index was off 1%. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #astrazeneca #vaccine #cancer #covid19 #news #press #release.